1 / 5

Global Lung Cancer Screening Software Market – Industry Trends and Forecast to 2029

Global Lung Cancer Screening Software Market, By Mode of Delivery (Cloud Based Solutions, On-Premise Solutions and Web Based Solutions), Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management Software, Nodule Management Software, Data Collection and Reporting, Patient Coordination and Workflow, Lung Nodule Computer Aided Detection, Pathology and Cancer Staging, Statistical Audit Reporting, Screening PACs, Practice Management and Audit Log Tracking), Type (Computer-Assisted Screening and Traditional Screening), Application (Non-Small Cell Lung Cancer (NSCLC)

pawarmnk
Download Presentation

Global Lung Cancer Screening Software Market – Industry Trends and Forecast to 2029

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Lung Cancer Screening Software Market – Industry Trends and Forecast to 2029 Control of lung cancer death rates is one of the major concerns for healthcare facilities. Public and private organizations are taking initiatives to launch screening programs to control the death rates. In addition, companies are launching advanced software to ease the management of patients’ data and provide better care with strict data privacy guidelines. Increase in prevalence of lung cancer, rising awareness among people about lung cancer, increasing government initiatives and growing number of screening programs are some of the major factors driving the growth of the market. In addition, advancement in Artificial Intelligence (AI)-based solutions and strategic initiatives by key market players are creating opportunities in the field of lung cancer screening software. https://www.databridgemarketresearch.com/reports/global-lung-cancer-screening-software-market Data Bridge Market Research analyzes that the global lung cancer screening software market is expected to reach the value of USD 115,027.61 thousand by 2029, at a CAGR of 19.4% during the forecast period. Cloud based solutions accounts for largest mode of delivery segment in the market. The market report also covers pricing analysis, patent analysis and technological advancements in depth. 

  2. Report Description Lung cancer screening is identifying stages of lung cancer using different technologies and software. Lung cancer screening using CT is the most recommended technique for screening lung cancer. The rising use of this technique is expected to accelerate the need for advanced software for lung cancer screening. This software helps to manage patients’ participation in lung screening programs and provides an efficient way for healthcare professionals to collect, curate and transfer data to clinicians and patients. In addition, this software enables in the identification of patients at risk and automates the flow of data with integrated electronic health records. https://www.databridgemarketresearch.com/reports/global-lung-cancer-screening-software-market Drivers Increase in prevalence of lung cancer cases globally Lung cancer is a leading cause of death in men and women. According to World Cancer Research Fund International, lung cancer is the second most common cancer worldwide. It is the most common cancer in men and second most common in women. There were more than 2.2 thousand new cases of lung cancer in 2020. Increasing prevalence of lung cancer cases creates need to adopt lung cancer screening software for early diagnosis and thus, acts as a driving factor for the market growth. Increase in awareness regarding the benefits of early diagnosis and frequent screening The rising awareness programs of lung cancer by public, non-profit and private organizations are anticipated to boost the market growth. These initiatives aim to prevent diseases, reduce stigma and prejudice and promote research. The awareness among the population regarding lung cancer has increased. Because there are many awareness programs by different organizations, people know about lung cancer that can be cured if diagnosed early. Thus, raising awareness among populations is driving the market growth.

  3. Market Overview • Recent Developments • In July 2022, GE Healthcare launched their latest product and most advanced ultrasound, the next-generation Voluson Expert 22. This latest addition to GE Healthcare’s award-winning Women’s Health portfolio utilizes graphic-based beam former technology, which produces higher quality images and offers greater flexibility in imaging functions. With this product, the company made its position much stronger in the area of products and service providers to healthcare institutions. • In October 2021, Thynk Health announced a partnership with Infervision, to fight lung cancer with the world’s most advanced technologies. It offers an opportunity for lung cancer screening and pulmonary nodule management. With this partnership, the company increased its market presence. • https://www.databridgemarketresearch.com/reports/global-lung-cancer-screening-software-market • Opportunity • Rising collaborations, mergers & acquisitions among the market players • The companies operating in the market are adopting several strategies, including mergers and acquisitions, product launches, agreements, pipeline development, collaborations and market expansion among others, to boost their business in various dimensions. These strategic decisions by the companies are expected to offer significant opportunities for the market players operating in the market.

  4. Key Players Competitive Landscape and Lung Cancer Screening Software Market Share Analysis The global lung cancer screening software market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market. Some of the major players operating in the market are PenRad Technologies Inc., Koninklijke Philips N.V, Volpara Health Limited, Thynk Health, Nuance Communications, Inc., Siemens Healthcare GmBH, MyCareWare, Inc., MagView, MeVis Medical Solutions AG, Canon Medical Informatics, Inc., General Electric Company, Epic Systems Corporation, Lungview, Eon, Medtronic, Coreline Soft, Co., Ltd., Optellum Ltd, HealthMyne, Oncocyte Corporation, Genesystem, REVEALDX, FUJIFILM Holdings Corporation, F. Hoffmann-La Roche Ltd, Median Technologies, AstraZeneca and Aidence.com among others. https://www.databridgemarketresearch.com/reports/global-lung-cancer-screening-software-market

  5. About Data Bridge Market Research An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth  the best market opportunities and foster efficient information for your business to thrive in the market. Contact Us:- Data Bridge Market Research US: +1 888 387 2818 UK: +44 208 089 1725 Hong Kong: +852 8192 7475 Email:- corporatesales@databridgemarketresearch.com

More Related